CN102784296B - Fructus trichosanthis oral liquid - Google Patents

Fructus trichosanthis oral liquid Download PDF

Info

Publication number
CN102784296B
CN102784296B CN 201210304244 CN201210304244A CN102784296B CN 102784296 B CN102784296 B CN 102784296B CN 201210304244 CN201210304244 CN 201210304244 CN 201210304244 A CN201210304244 A CN 201210304244A CN 102784296 B CN102784296 B CN 102784296B
Authority
CN
China
Prior art keywords
radix
oral liquid
neurodermatitis
leukoplakia
psoriasis vulgaris
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 201210304244
Other languages
Chinese (zh)
Other versions
CN102784296A (en
Inventor
徐海波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201210304244 priority Critical patent/CN102784296B/en
Publication of CN102784296A publication Critical patent/CN102784296A/en
Application granted granted Critical
Publication of CN102784296B publication Critical patent/CN102784296B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a new traditional Chinese medicine oral liquid for treating psoriasis vulgaris as the main, and chronic simple lichen (neurodermatitis) and vulval leukoplakia, which is mainly prepared from 12 traditional Chinese medicine components, such as fructus trichosanthis and fructus mume. The oral liquid has certain curative effect for psoriasis vulgaris, chronic simple lichen (neurodermatitis) and vulval leukoplakia. The oral liquid is scientific in prescription and significant in curative effect.

Description

The Fructus Trichosanthis oral liquid
Technical field
The present invention relates to a kind for the treatment of take psoriasis vulgaris and is the oral medicine of main and chronic simple lichen (neurodermatitis), leukoplakia of vulva, oral liquid prepared as raw material by the Chinese herbal medicine of specifically take.
Background technology
Motherland's medical science is such description to psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva: the wanting of negative and positive, sun is close is solid.YIN and YANG in a relative equilibrium, life activities being normally maintained.Seasonal pathogens,exopathogens, the growth of wood fire department, the collection of Jinsui River department.Prevailing of the wind edema with the liver involved sparrow hawk is opened, the order of lumber yard catharsis, and the power of golden misconvergence, and pathogenic wind is too prosperous, is not subject to the gold system, the anti-gold of insulting, gold gas loses to be received, and clear respectful not all right, gold is Jellyfish, and aqueous vapor is lost root, the withered consumption of body fluid, the moon damage under, and the duty of keeping in losing, sun is lonely in upper, it is dry that lung is suffered from, the dryness of the lung is itched.The case of always treating psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva is mainly with diverging and dispelling wind-evil for controlling, but so far there are no, desirable, the authoritative medicament of potion curative effect comes out.
Summary of the invention
The object of the present invention is to provide and a kind ofly take the treatment psoriasis vulgaris and be the oral medicine of main and chronic simple lichen (neurodermatitis), leukoplakia of vulva, its disease for skin pruritus, rough surface plumpness provides a kind of convenience, effective, oral medicine without any side effects " oral liquid ".
Solution of the present invention is that the inventor is based on psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva in motherland's theory of medicine: the relatively catharsis of person wood fire, gold gas is rushed and the order of misconvergence, aqueous vapor is let out, and the energy of mistake envelope Tibetan, water not intrinsic energy mutually fiery beneficial thing soar, the Jin Bushou beneficial thing of wind wood lets out, the part of the body cavity above the diaphragm housing the heart and lungs is body fluid wound and steam extrusion, the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels mutually fire let out and order hollow, middle Jiao in weakness of QI lose and hand over Ji incompetent.Wind and vital-QI fighting each other, prevailing of the wind is urticaria, health is for itching, itching being called wind-leaking, itching caused by urticaria lasting a long time leading to scabs and tinea.So medical scheme of taking: " liver is bitter anxious, anxious food sweet flavor has the effect of relaxing, acid is rushed down it, suitable its property and decline also." slow liver is suddenly with endogenous wind stopping, lung moistening is dry with wood processed.
The clinical experience that the inventor sums up 14 years think because following " liver is bitter anxious, anxious food sweet flavor has the effect of relaxing, acid is rushed down it, suitable its property and decline also." theory, progressively grope to sum up its Therapeutic Principle from many cases psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva patient: slow liver is anxious with endogenous wind stopping, and lung moistening is dry with wood processed.In conjunction with motherland's medical science theories, drawn selectively the prescription elite of motherland's medical science related disorders, filter out the prescription of the Chinese herbal medicine science of significant curative effect, develop the Chinese medicine oral liquid of specially controlling psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva, its clinical manifestation is gone out: the disease of skin pruritus, rough surface plumpness, treat targetedly, reach desirable curative effect, the wood invention is made (consumption is unit of weight) by following component.
Fructus Trichosanthis 20-25 Fructus Mume 20-25 Rhizoma Dioscoreae 10-15
Radix Ophiopogonis 10-15 Bulbus Lilii 10-15 Rhizoma Polygonati Odorati 10-15
Radix Angelicae Sinensis 10-15 Radix Paeoniae Alba 10-15 Rhizoma Pinelliae Preparatum 10-15
Flos Sophorae 10-15 Radix Glehniae 10-15 Radix Glycyrrhizae 10-15
Medical material weight of the present invention (part) proportioning is:
24 24 12 Radix Ophiopogonis 12 of Rhizoma Dioscoreae of Fructus Mume of Fructus Trichosanthis
Bulbus Lilii 12 Rhizoma Polygonati Odorati 12 Radix Angelicae Sinensis 12 Radix Paeoniae Albas 12
Rhizoma Pinelliae Preparatum 12 Flos Sophorae 12 Radix Glehniae 12 Radix Glycyrrhizae 12
Making preparation method of the present invention by above-mentioned each component is:
1, by each raw material of Chinese medicine medicine in prescription routinely the traditional Chinese medicine decocting method decoct afterwards concentrated;
2, medicinal liquid is sealed up for safekeeping well by every 20ml fill with filling machine.
Fructus Trichosanthis oral liquid of the present invention has following advantage:
Can make psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva at short notice skin lesion disappear more than 30%, chronic simple lichen (neurodermatitis), leukoplakia of vulva after two courses for the treatment of skin lesion disappear and reach 80%-90%, other transference cures.Psoriasis vulgaris 3-5 month clinical cure, without auxiliary therapy.Fructus Trichosanthis in side, sweet cold, the suppressing the hyperactive liver emergency, eliminate Liang Run; Fructus Mume, acid is flat, sour and astringent convergence, acid, with the eliminating pathogen in the liver tonifying the lung, is rushed down the only catharsis of wind wood; With Fructus Trichosanthis, share, is principal agent altogether.Rhizoma Dioscoreae, sweet flat, QI invigorating tonifying the lung, yin nourishing stomach invigorating, the dry only catharsis of endogenous wind stopping; Radix Ophiopogonis, sweet flat, reinforcing stomach reg fluid, nourishing lung-YIN: Bulbus Lilii, sweet flat, invigorating the spleen and replenishing QI, clearing heat in the lung is moisturized; Rhizoma Polygonati Odorati, sweet flat, the nourishing the stomach of promoting the production of body fluid, nourishing YIN and moistening the lung, mend golden endogenous wind stopping; Radix Angelicae Sinensis, sweet, enrich blood and invigorate blood circulation, moisten sliding pool; The Radix Paeoniae Alba, bitter flat, the yin fluid astringing that nourishes blood, the suppressing the hyperactive liver easing the affected liver, fresh breeze is dry and hold back catharsis, makes the liver blood foot and wind is fixed; Be ministerial drug altogether.Rhizoma Pinelliae Preparatum, hot flat, fall and take the photograph gastric qi, therapeutic method to keep the adverse QI flowing downwards stomach function regulating, and do not dislike it dry with a large amount of clear and rich compatibility of drugss: Flos Sophorae, hardship is slightly cold, and removing heat from blood fresh breeze is controlled the scabies skin wind of dispelling; Radix Glehniae, hardship is slightly cold, reinforcing stomach reg fluid, clearing lung and nourishing yin, dredging and not dry, moist and not stagnant; Be adjuvant drug altogether.Radix Glycyrrhizae, sweet flat, relax the property of medicine, coordinating the actions of various ingredients in a prescription is for making medicine.
Use pharmaceutical methods of the present invention: each one (20ml), every day three times, taking medicine before meal.Ten days courses for the treatment of of chronic simple lichen (neurodermatitis), leukoplakia of vulva, a month course for the treatment of of psoriasis vulgaris, totally three to five courses for the treatment of.
For showing the therapeutic effect of medicine of the present invention to psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva, the present invention is through 100 routine system clinical observations, wherein: psoriasis vulgaris 60 examples, chronic simple lichen (neurodermatitis), each 20 examples of leukoplakia of vulva, and selection medical history, the state of an illness, age, sex and suitable psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva patient 73 examples of former treatment are matched group.From being in hospital and special outpatient clinic, select case, " disease of tcm Standardization of diagnosis and curative effect " according to State Administration of Traditional Chinese Medicine's formulation in 1994, the psoriasis vulgaris of making a definite diagnosis, chronic simple lichen (neurodermatitis), leukoplakia of vulva patient are the object of observation, male's 50 examples wherein, women's 50 examples, age 18-70 year, the course of disease is from starting the phase to 20 year.Test group: on use or the basis without the initial stage medicine for external use, discontinue medication, take medicine of the present invention.Matched group: Therapeutic Method is used medicine for external use commonly used routinely, and in, western oral medicine.Two of medicine for external use group usage, consumptions are complementary, 12 months observation periods, ten days courses for the treatment of of chronic simple lichen (neurodermatitis), leukoplakia of vulva, a month course for the treatment of of psoriasis vulgaris, totally three courses for the treatment of.
Use pharmaceutical methods of the present invention: one day three, each (20ml) oral liquid, ante cibum is oral.A month course for the treatment of.
Test group, matched group, after three months courses for the treatment of, the curative effect situation sees the following form:
The curative effect information slip
Figure BSA00000768175600031
After test group is taken medicine of the present invention as can be seen from the table, cardinal symptom disappears, and skin lesion disappears, and therapeutic effect is obvious.Clinical 14 years of inventor, accept more than 200 examples for medical treatment, effective percentage 95% (wherein cure rate 82%), inefficiency 5%.
The specific embodiment
Embodiment.Treating of psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva.
1, the composition of medicine and proportioning:
Fructus Trichosanthis 24g Fructus Mume 24g Rhizoma Dioscoreae 12g 12g Radix Ophiopogonis
Bulbus Lilii 12g Rhizoma Polygonati Odorati 12g Radix Angelicae Sinensis 12g Radix Paeoniae Alba 12g
Rhizoma Pinelliae Preparatum 12g Flos Sophorae 12g Radix Glehniae 12g Radix Glycyrrhizae 12g
2, manufacture method and use:
By each raw material of Chinese medicine medicine in prescription, Chinese medicine decocting, the method for enduring are decocted routinely; Medicinal liquid is filled with by every 20ml with filling machine, seal up for safekeeping.One day three, each (20ml) oral liquid, ante cibum is oral, ten days courses for the treatment of of chronic simple lichen (neurodermatitis), leukoplakia of vulva, a month course for the treatment of of psoriasis vulgaris, adheres to using, and more than 10 years, does not recur.

Claims (2)

1. a Chinese medicine oral liquid for the treatment of psoriasis vulgaris is characterized in that each raw material forms, weight proportion is:
Fructus Trichosanthis 20-25 Fructus Mume 20-25 Rhizoma Dioscoreae 10-15
Radix Ophiopogonis 10-15 Bulbus Lilii 10-15 Rhizoma Polygonati Odorati 10-15
Radix Angelicae Sinensis 10-15 Radix Paeoniae Alba 10-15 Rhizoma Pinelliae Preparatum 10-15
Flos Sophorae 10-15 Radix Glehniae 10-15 Radix Glycyrrhizae 10-15.
2. Chinese medicine oral liquid according to claim 1, wherein each raw material weight proportioning is:
Fructus Trichosanthis 24g Fructus Mume 24g Rhizoma Dioscoreae 12g 12g Radix Ophiopogonis
Bulbus Lilii 12g Rhizoma Polygonati Odorati 12g Radix Angelicae Sinensis 12g Radix Paeoniae Alba 12g
Rhizoma Pinelliae Preparatum 12g Flos Sophorae 12g Radix Glehniae 12g Radix Glycyrrhizae 12g.
CN 201210304244 2012-08-19 2012-08-19 Fructus trichosanthis oral liquid Expired - Fee Related CN102784296B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210304244 CN102784296B (en) 2012-08-19 2012-08-19 Fructus trichosanthis oral liquid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210304244 CN102784296B (en) 2012-08-19 2012-08-19 Fructus trichosanthis oral liquid

Publications (2)

Publication Number Publication Date
CN102784296A CN102784296A (en) 2012-11-21
CN102784296B true CN102784296B (en) 2013-12-18

Family

ID=47150014

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210304244 Expired - Fee Related CN102784296B (en) 2012-08-19 2012-08-19 Fructus trichosanthis oral liquid

Country Status (1)

Country Link
CN (1) CN102784296B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105213971B (en) * 2015-10-15 2019-01-22 广东省中医院 The Chinese medicine composition for treating psoriasis
CN106822665A (en) * 2017-04-11 2017-06-13 李梦 Chinese medicine composition and medicament and preparation method for treating psoriasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1058631C (en) * 1998-01-22 2000-11-22 唐山市京东皮肤病研究所 Psoriasis capsule
CN102210811B (en) * 2011-05-27 2012-07-04 徐海波 Dark plum oral solution

Also Published As

Publication number Publication date
CN102784296A (en) 2012-11-21

Similar Documents

Publication Publication Date Title
CN103127378B (en) Chinese medicinal composition for treating rheumatic heart disease
CN103120791B (en) A kind of Chinese medicine composition for the treatment of viral myocarditis and preparation method thereof
CN102210811B (en) Dark plum oral solution
CN103316317A (en) Traditional Chinese medicine composition for treating superficial gastritis
CN102784296B (en) Fructus trichosanthis oral liquid
CN102430091B (en) Chinese medicinal composition for treating children cough
CN104740330A (en) Traditional Chinese medicine oral decoction for treating chronic pharyngitis
CN102949685A (en) Traditional Chinese medicine composition for treating chronic gastritis
CN102973785B (en) Traditional Chinese medicine for treatment of diabetic cardiomyopathy
CN105233004A (en) Medicine for treating chronic gastritis
CN103599430B (en) A kind of Chinese medicine composition being used for the treatment of cardiac asthma
CN103110811B (en) Traditional Chinese medicine composition for treating arrhythmia
CN106075265A (en) The Chinese medicine composition for the treatment of viral influenza
CN103191281B (en) Dried rehamnnia root oral liquid
CN102764374B (en) Traditional Chinese medicine powder for treating peptic ulcer
CN101259186B (en) Medicinal and edible dual-purpose powder for treating milk unsmooth and mammary swelling pain
CN101716326B (en) Medicament for treating children chronic cough and allergic rhinitis and preparation method thereof
CN102885952B (en) South dodder seed oral liquid
CN104042839A (en) Traditional Chinese medicine composition for treating tinea versicolor
CN103417861A (en) Traditional Chinese medicine composition for treating chronic cardiac insufficiency
CN104721435A (en) Cough and asthma relieving powder
CN104161922A (en) Traditional Chinese medicine for treating qi deficiency-type cough
CN103599508B (en) One is used for the treatment of the uremic Chinese medicine composition of children's
CN108079073A (en) It is a kind of steep pedicure tremble with fear foot alleviate medicine Chinese medicine powder
CN105343298A (en) Navel patch for treating chronic constipation and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131218

Termination date: 20200819